Viatris, Inc. Hits New 52-Week High of $17.93, Up 69.93% Year-Over-Year

Viatris, Inc., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 17.93 on July 28, 2026. This achievement marks a remarkable 69.93% increase in the stock's performance over the past year, significantly outpacing the S&P 500's growth of 16.26% during the same period. The company's market capitalization stands at USD 15,347 million, reflecting its solid position within the industry. Viatris has a dividend yield of 84.69%, indicating a strong return for shareholders despite its current loss-making status, as evidenced by its negative return on equity of -0.46%. The stock's price-to-book ratio is 1.04, suggesting that it is trading close to its book value. With a debt-to-equity ratio of 0.89, Viatris maintains a balanced approach to leveraging its capital structure. The stock's previous 52-week low was recorded at USD 8.63, highlighting the significant upward movement it has experienced in recent months.